Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+4.2%
5Y CAGR+9.4%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+4.2%/yr
Annual compound
5Y CAGR
+9.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 54.50% | +15.1% |
| 2024 | 47.36% | +57.6% |
| 2023 | 30.06% | -37.5% |
| 2022 | 48.12% | +28.9% |
| 2021 | 37.33% | +7.4% |
| 2020 | 34.76% | +11.6% |
| 2019 | 31.16% | +100.4% |
| 2018 | -7051.44% | - |